Skip to main content
ABT
NYSE Life Sciences

Abbott Reports In-Line Q1 Results, Updates FY26 Guidance Post-Exact Sciences Acquisition

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$99.25
Mkt Cap
$176.883B
52W Low
$99.05
52W High
$139.06
52W Position info
0.2% above low
Off High info
29% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

ABT is trading near its 52-week low of $99.05 (0.2% above the low).

Summary

Abbott Laboratories reported first-quarter results aligned with expectations and updated its full-year guidance, incorporating the financial impact of the recently completed Exact Sciences acquisition.


Key Events · Earnings and Guidance · ABT

  • First-Quarter 2026 Results Announced

    Abbott reported first-quarter GAAP diluted EPS of $0.61 and adjusted diluted EPS of $1.15, reflecting 6 percent growth. Sales increased 7.8 percent on a reported basis and 3.7 percent on a comparable basis, aligning with expectations.

  • Full-Year 2026 Guidance Updated

    The company projects full-year 2026 comparable sales growth of 6.5% to 7.5% and adjusted diluted EPS of $5.38 to $5.58. This guidance includes a $0.20 per share dilution related to the Exact Sciences acquisition.

  • Exact Sciences Acquisition Completed

    Abbott completed its acquisition of Exact Sciences on March 23, 2026, establishing a leadership position in the oncology diagnostics market and adding a new high-growth vertical to its portfolio.

  • Positive Product Development Updates

    Abbott announced a collaboration for a next-generation EV-ICD system, positive early results for the Amulet 360™ Left Atrial Appendage Occluder, and clinically meaningful HbA1c reduction with FreeStyle Libre® in Type 2 diabetes patients.


Analysis · ABT · Life Sciences

This filing provides Abbott's official first-quarter results, which were aligned with expectations. Crucially, it updates the full-year 2026 financial guidance to reflect the recently completed Exact Sciences acquisition, quantifying its dilutive impact while maintaining a positive outlook for accelerating growth. This clarity on future performance, combined with positive product development news, is important for investors, especially with the stock trading near its 52-week low, as it provides a baseline for future valuation.

How filings like this one have moved

In the 30 days to Nov 3, 2026, 32.3% of the 2077 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ABT was trading at $99.25 on NYSE in the Life Sciences sector, with a market capitalization of approximately $176.9B. The 52-week trading range was $99.05 to $139.06. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ABT - Latest Insights

ABT
Oct 21, 2026, 8:53 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $98.21
Real-time Price: $109.81 info
Change: +$11.60 (+12%) info
Market Cap: $190.619B info
ABT
Oct 21, 2026, 7:36 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $99.52
Real-time Price: $109.81 info
Change: +$10.29 (+10%) info
Market Cap: $190.619B info
ABT
Oct 21, 2026, 7:32 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $100.55
Real-time Price: $109.81 info
Change: +$9.26 (+9%) info
Market Cap: $190.619B info
ABT
Oct 21, 2026, 7:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $100.52
Real-time Price: $109.81 info
Change: +$9.29 (+9%) info
Market Cap: $190.619B info
ABT
Oct 05, 2026, 9:00 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $97.53
Real-time Price: $109.81 info
Change: +$12.28 (+13%) info
Market Cap: $190.619B info